Friday , 21 February 2025
0

No products in the cart.

Worldwide News Worldwide News
0

No products in the cart.

Home Health Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin
Health

Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin

November 21, 20241 Mins read29 Views
Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin

Kura Oncology already had a broad development plan for ziftomenib in leukemias, but the agreement with Kyowa Kirin provides the cash to execute it and a partner to commercialize the drug globally. Ziftomenib is in the same class of medicines as Syndax Pharmaceuticals’ Revuforj, which won FDA approval last week.

The post Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin appeared first on MedCity News.

Previous post USDCHF moves above converged 100 and 200 hour MAs and rockets higher

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Health

This year’s ViVE conference was full of announcements — from acquisitions to...

ByFebruary 21, 2025
Health

Do you think hormones cause mood swings in women only?It is not...

ByFebruary 20, 2025

PEPFAR, the U.S. global HIV/AIDS program, is - for the first time...

ByFebruary 20, 2025

In Feedspot’s 2025 rankings, Healthcare Economist was once again ranked in the...

ByFebruary 20, 2025

Abous us

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis

Subscribe Now

    Subscribe to our mailing list to receives daily updates direct to your inbox!
    © Copyright 2022 Jellywp. All rights reserved powered by Jellywp.com